XCell Therapeutics Inc banner
X

XCell Therapeutics Inc
KOSDAQ:373110

Watchlist Manager
XCell Therapeutics Inc
KOSDAQ:373110
Watchlist
Price: 1 140 KRW -3.23% Market Closed
Market Cap: ₩19.7B

Wall St Price Targets

Price Targets Summary
XCell Therapeutics Inc

There are no price targets for XCell Therapeutics Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
XCell Therapeutics Inc Competitors:
Price Targets
ACIU
AC Immune SA
217% Upside
1981
Cathay Media and Education Group Inc
70% Upside
PTCT
PTC Therapeutics Inc
37% Upside
STRO
Sutro Biopharma Inc
127% Upside
EOLS
Evolus Inc
66% Upside

Revenue
Forecast

32% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
32% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for XCell Therapeutics Inc

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for XCell Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for XCell Therapeutics Inc

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for XCell Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for XCell Therapeutics Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is XCell Therapeutics Inc's stock price target?
Not Available

XCell Therapeutics Inc does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett